Clinical trial of LMB-100 in patients with pancreatic cancer

Trial Profile

Clinical trial of LMB-100 in patients with pancreatic cancer

Active, no longer recruiting
Phase of Trial: Phase I

Latest Information Update: 11 May 2017

At a glance

  • Drugs LMB 100 (Primary)
  • Indications Pancreatic cancer
  • Focus Adverse reactions
  • Most Recent Events

    • 11 May 2017 New trial record
    • 02 May 2017 According to a Selecta Biosciences media release, Center for Cancer Research (CCR) is in the process of completing this trial.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top